Desketoraloxifene
CAS No. 216570-81-9
Desketoraloxifene( —— )
Catalog No. M23980 CAS No. 216570-81-9
Desketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 272 | In Stock |
|
| 10MG | 409 | In Stock |
|
| 25MG | 737 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDesketoraloxifene
-
NoteResearch use only, not for human use.
-
Brief DescriptionDesketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).
-
DescriptionDesketoraloxifene is a selective estrogen receptor modulator, inhibiting mammalian PLD (PLD1 and PLD2).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPhospholipase
-
RecptorPLD1|PLD2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number216570-81-9
-
Formula Weight445.57
-
Molecular FormulaC27H27NO3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC1CCN(CC1)CCOC2=CC=C(C=C2)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Scott S A , Spencer C T , MC O’Reilly, et al. Discovery of Desketoraloxifene Analogues as Inhibitorsof Mammalian, Pseudomonas aeruginosa, and NAPE PhospholipaseD Enzymes[J]. Acs Chemical Biology, 2015, 10(2):421.
molnova catalog
related products
-
PHPS1
PHPS1 is an inhibitor of Shp2. PHPS1 efficiently inhibits activation of Erk1/2 by the leukemia-associated Shp2 mutant, Shp2-E76K, and blocks the anchorage-independent growth of a variety of human tumor cell lines.
-
Lp-PLA2-IN-3
Lp-PLA2-IN-3 is a potent, orally bioactive lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor, effectively inhibiting recombinant human [Lp-PLA2] with an IC50 value of 14 nM.
-
U73122
U73122 is a potent phospholipase C (PLC) inhibitor, which reduces agonist-induced Ca2+ increases in platelets and PMN.
Cart
sales@molnova.com